Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Steven Mah's Stock Ratings
TD Cowen Analyst
Steven Mah is an analyst at TD Cowen. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/16/2025
Updated: Dec 16, 2025
Overall Average Return
11.1%
Smart Score
Overall Average Return Percentile
60th
Number of Ratings
43
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 11/26/2024 | TWST | Buy Now | Twist Bioscience | $30.48 | 90.29% | $58 → $58 | Reiterates | Buy → Buy | Get Alert | |
| 11/13/2024 | BLFS | Buy Now | BioLife Solns | $24.65 | 25.76% | $28 → $31 | Maintains | Buy | Get Alert | |
| 07/17/2024 | BLFS | Buy Now | BioLife Solns | $24.65 | 5.48% | $20 → $26 | Maintains | Buy | Get Alert | |
| 06/13/2024 | TWST | Buy Now | Twist Bioscience | $30.48 | 113.25% | $55 → $65 | Maintains | Buy | Get Alert | |
| 03/01/2024 | DNA | Buy Now | Ginkgo Bioworks Holdings | $8.56 | -64.95% | $7 → $3 | Maintains | Outperform | Get Alert | |
| 01/26/2024 | RXRX | Buy Now | Recursion Pharmaceuticals | $4.16 | — | — | Initiates | → Market Perform | Get Alert | |
| 01/26/2024 | SDGR | Buy Now | Schrodinger | $18.14 | 131.53% | → $42 | Initiates | → Outperform | Get Alert | |
| 08/23/2023 | CELL | Buy Now | PhenomeX | — | — | → $1 | Downgrade | Outperform → Market Perform | Get Alert | |
| 02/28/2023 | ABCL | Buy Now | AbCellera Biologics | $3.48 | — | — | Initiates | → Outperform | Get Alert | |
| 02/22/2023 | OABI | Buy Now | OmniAb | $2.03 | 392.61% | → $10 | Initiates | → Outperform | Get Alert | |
| 09/22/2022 | ME | Buy Now | 23andMe Holding | — | — | → $6 | Initiates | → Outperform | Get Alert | |
| 08/12/2022 | ABSI | Buy Now | Absci | $3.39 | — | — | Upgrade | Market Perform → Outperform | Get Alert | |
| 07/15/2022 | CDXS | Buy Now | Codexis | $1.63 | 1188.34% | $39 → $21 | Maintains | Outperform | Get Alert | |
| 03/02/2022 | DNA | Buy Now | Ginkgo Bioworks Holdings | $8.56 | 40.19% | → $12 | Initiates | → Outperform | Get Alert | |
| 08/12/2021 | TLIS | Buy Now | Talis Biomedical | $1.60 | 462.5% | → $9 | Downgrade | Overweight → Neutral | Get Alert | |
| 08/04/2021 | HSKA | Buy Now | Heska | — | — | $240 → $305 | Maintains | Overweight | Get Alert | |
| 07/06/2021 | NTRA | Buy Now | Natera | $226.99 | -31.72% | $150 → $155 | Maintains | Overweight | Get Alert | |
| 05/11/2021 | AKYA | Buy Now | Akoya Biosciences | — | — | → $28 | Initiates | → Overweight | Get Alert | |
| 04/13/2021 | LMNX | Buy Now | Luminex | $36.00 | 2.78% | $38 → $37 | Downgrade | Overweight → Neutral | Get Alert | |
| 04/12/2021 | TWST | Buy Now | Twist Bioscience | $30.48 | 392.13% | → $150 | Initiates | → Overweight | Get Alert | |
| 04/12/2021 | CDXS | Buy Now | Codexis | $1.63 | 1863.19% | → $32 | Initiates | → Overweight | Get Alert | |
| 03/09/2021 | TLIS | Buy Now | Talis Biomedical | $1.60 | 962.5% | → $17 | Initiates | → Overweight | Get Alert | |
| 03/05/2021 | FLGT | Buy Now | Fulgent Genetics | $26.92 | 420.06% | $135 → $140 | Maintains | Overweight | Get Alert | |
| 02/26/2021 | NTRA | Buy Now | Natera | $226.99 | -33.92% | $127 → $150 | Maintains | Overweight | Get Alert | |
| 02/24/2021 | HSKA | Buy Now | Heska | — | — | $157 → $220 | Maintains | Overweight | Get Alert | |
| 02/22/2021 | OCDX | Buy Now | Ortho Clinical Diagnostic | — | — | → $27 | Initiates | → Overweight | Get Alert | |
| 02/11/2021 | PACB | Buy Now | Pacific Biosciences | $2.11 | 2368.67% | $20 → $52 | Upgrade | Neutral → Overweight | Get Alert | |
| 01/07/2021 | OXFD | Buy Now | Oxford Immunotec Global | — | — | $24 → $22 | Downgrade | Overweight → Neutral | Get Alert | |
| 12/22/2020 | ILMN | Buy Now | Illumina | $134.92 | 207.59% | $340 → $415 | Upgrade | Neutral → Overweight | Get Alert | |
| 12/16/2020 | OCX | Buy Now | OncoCyte | — | — | $2 → $4 | Upgrade | Neutral → Overweight | Get Alert | |
| 11/03/2020 | PACB | Buy Now | Pacific Biosciences | $2.11 | — | — | Downgrade | Overweight → Neutral | Get Alert | |
| 10/01/2020 | PACB | Buy Now | Pacific Biosciences | $2.11 | 469.69% | $6 → $12 | Maintains | Overweight | Get Alert | |
| 08/07/2020 | ILMN | Buy Now | Illumina | $134.92 | 152% | $356 → $340 | Downgrade | Overweight → Neutral | Get Alert | |
| 07/27/2020 | FLGT | Buy Now | Fulgent Genetics | $26.92 | 15.16% | $21 → $31 | Maintains | Overweight | Get Alert | |
| 07/08/2020 | QDEL | Buy Now | QuidelOrtho | $28.90 | 765.05% | $168 → $250 | Maintains | Overweight | Get Alert | |
| 06/17/2020 | FLGT | Buy Now | Fulgent Genetics | $26.92 | -21.99% | $18 → $21 | Maintains | Overweight | Get Alert | |
| 05/14/2020 | NTRA | Buy Now | Natera | $226.99 | -75.33% | $49 → $56 | Maintains | Overweight | Get Alert | |
| 02/27/2020 | NTRA | Buy Now | Natera | $226.99 | -78.41% | $45 → $49 | Reiterates | → Overweight | Get Alert | |
| 01/09/2020 | ILMN | Buy Now | Illumina | $134.92 | 174.24% | $341 → $370 | Maintains | Overweight | Get Alert | |
| 10/25/2019 | ILMN | Buy Now | Illumina | $134.92 | 152.74% | $348 → $341 | Maintains | Overweight | Get Alert | |
| 11/03/2015 | LMNX | Buy Now | Luminex | $36.00 | -47.22% | $17 → $19 | Maintains | Neutral | Get Alert | |
| 07/09/2012 | LMNX | Buy Now | Luminex | $36.00 | -50% | $21 → $18 | Maintains | Underweight | Get Alert | |
| 05/01/2012 | LMNX | Buy Now | Luminex | $36.00 | -41.67% | $19 → $21 | Maintains | Underweight | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved